Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.22 +0.02 (+0.48%)
At close: Nov 11, 2026 · 4:00 PM EST

Atea Pharmaceuticals (AVIR) Return on Assets [ROA] (2020 - 2026)

Updated

Atea Pharmaceuticals' Return on Assets [ROA] came in at -66.20% for Q2 2026, down 33.46 percentage points from -32.74% a year earlier and down 7.98 percentage points from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Atea Pharmaceuticals' Return on Assets [ROA] was -40.61%, down 8.83 percentage points from FY2024.

  • Return on Assets [ROA] has declined in each of the last four years, with a five-year change of -38.14 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -31.78% in FY2024 (-10.23 pp), -21.55% in FY2023 (-5.45 pp), -16.10% in FY2022 (-30.91 pp) and 14.81% in FY2021 (+17.28 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] in data going back to Q4 2020.
  • Year-over-year, Return on Assets [ROA] has declined for four consecutive quarters, with an average year-over-year change of -13.39 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2021 (a gain of 17.24 percentage points), and the weakest in Q2 2026 (a drop of 33.46 percentage points).
  • Business Quant data shows AVIR's Return on Assets [ROA] at -58.22% (Q1 2026), -48.12% (Q4 2025) and -40.03% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Atea Pharmaceuticals 337.28 Mn -631.22 Mn - -71.92%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -71.92%
Jun 30, 2026 -66.25%
Mar 31, 2026 -58.30%
Dec 31, 2025 -48.14%
Sep 30, 2025 -40.14%
Jun 30, 2025 -32.66%
Mar 31, 2025 -30.77%
Dec 31, 2024 -35.24%
Sep 30, 2024 -34.57%
Jun 30, 2024 -33.09%
Mar 31, 2024 -28.49%
Dec 31, 2023 -22.45%
Sep 30, 2023 -21.17%
Jun 30, 2023 -16.84%
Mar 31, 2023 -16.80%
Dec 31, 2022 -17.23%
Sep 30, 2022 5.04%
Jun 30, 2022 2.20%
Mar 31, 2022 6.50%
Dec 31, 2021 15.00%
API Access

Atea Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEY